Dana Larocca has over 20 years of leadership experience in Biotechnology. At ReCyte Therapeutics, she served as VP of Research and Development. She was founder and CEO of Mandala Biosciences, LLC where she raised over $3M in non-dilutive funding. Dr. Larocca previously held joint positions at Advanced Cell Technology (Astellas) and Sanford Burnham Prebys Medical Discovery Institute. She has over 40 scientific publications and 25 patents. Dr. Larocca holds a Ph.D. in Molecular and Cellular Biology from the University of Southern California and a B.S. in Biology from Ithaca College. She did her post-doctoral training at Harvard University.